All Type of News
7 out of 10 babies suffer from atopic dermatitis73.8 percent of infants aged under 0-4 years in Korea are suffering from atopic dermatitis and asthma, a recent survey said.
Stifel Korea, a skin care manufacturer of Physiog...
|
Xceed selected as 2006 Power Hit ItemAt the 2006 Best-Selling Brand Festival at the Korea Brand Association in Seoul, the committee said Abbott Korea's Xceed blood glucose monitor was one of power hit items in 2006...
|
Positive list system never acceptable in KORUS FTA
In the FTA talk meeting between Korea and the United States called KORUS FTA, the United States side had kept a firm stance for the positive list system, a drug pricing policy actively promoted by the MOHW of Korea, n...
KPA to raise solution for drug supply shortage problems.
A system reform requires for the future drug supply shortage problems by taking an occasion with GSK's supply shortage incidence of Pritor Plus tablet in May without any prior notice, which was caused simply by the su...
Foreign investors target Chong Kun Dang Pharmaceutical
Foreign investors have been aggressively buying shares of Chong Kun Dang Pharmaceutical and Hanmi Pharm, according to the recent survey of Yakup Shinmoon.
Stock price of Chong Kun Dang is hovering around 32,000 won...
KFDA to designate clinical centers for medical device
The Korea Food and Drug Administration said on June 12 that it will formulate a rule to designate clinical centers for medical device
The designation will not only improve the infrastructure of clinical trials for ...
ReNu MultiPlus is safe, Bausch & Lomb Korea says
After Bausch & Lomb Inc. decided to recall its ReNu with MoistureLoc contact lens solution in the U.S. market, which has been linked to dozens of cases of a serious eye infection, ReNu MultiPlus is gradually restoring...
Profitable business to permit for honest hospitals.
A profitable business seems to be allowed for the honest hospital having a transparent accounting practice by an outside accounting and auditing company. The M&A process in the hospital areas will be also simplified.
...
Novartis and Seoul Asan hospital to agree clinical R&D.Novartis Korea and Seoul Asan hospital have singed an agreement for the clinical R&D cooperation covering that Seoul Asan hospital establishes "Novartis Clinical Research Office...
|
Korea needs to learn from Novartis's 60-year natural products research
Korea aims to become one of the world's top seven countries in natural substance research and development by developing at least six new medicines by 2010.
Under the projects, the Korean government plans to develop...
